Full Text View
Tabular View
Study Results
Related Studies
Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
This study has been completed.
Study NCT00110513   Information provided by GTC Biotherapeutics

First Received on May 10, 2005.   Last Updated on August 10, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Antithrombin III Deficiency
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Blood Protein Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Thrombophilia
Additional drug interventions recognized in this trial
Antithrombin III
Antithrombin Proteins
Antithrombins
More general drug interventions related to this trial
Anticoagulants
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Serine Proteinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
GTC Biotherapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services